Search for: "Janssen Pharmaceuticals Inc." Results 21 - 40 of 243
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Apr 2010, 2:06 am by Ben Vernia
“The Corporate Integrity Agreement requires Ortho-McNeil-Janssen-Pharmaceuticals, Inc. to increase transparency and accountability and to make changes designed to avoid illegal drug promotion in the future. [read post]
4 Nov 2013, 3:04 am by Ben Vernia
On November 4, the Department of Justice announced that Johnson & Johnson and its subsidiaries, Janssen Pharmaceuticals, Inc., and Scios, Inc., had agreed to pay $2.2 billion to resolve claims originally brought by whistleblowers that the company promoted its drugs Risperdal, Invega, and Natrecor for unapproved (off-label) uses. [read post]
17 Jun 2012, 9:55 pm by Patent Docs
Searle, LLC • Defendants: Hetero Drugs, Ltd., Unit III; Invagen Pharmaceuticals, Inc. [read post]
31 Aug 2016, 1:31 pm by ccladm
Janssen Pharmaceuticals, Inc. on May 11th, and ruled that Janssen neglected to make an effort to warn physicians of the risks regarding Topamax. [read post]
31 Aug 2016, 1:31 pm by ccladm
Janssen Pharmaceuticals, Inc. on May 11th, and ruled that Janssen neglected to make an effort to warn physicians of the risks regarding Topamax. [read post]
26 Sep 2017, 12:46 pm by Associated Press
About a dozen pharmaceutical companies, including Purdue Pharma L.P., Janssen Pharmaceuticals Inc. and Allergan PLC, filed a brief Friday saying they’ve complied with the U.S. [read post]
23 Jun 2013, 8:50 pm by Patent Docs
Par Pharmaceutical Inc. et al. 1:13-cv-01104; filed June 19, 2013 in the District Court of Delaware • Plaintiffs: Alza Corp.; Janssen Pharmaceuticals Inc. [read post]
18 May 2010, 7:03 pm by Carey, Danis & Lowe
A recent $81 million settle between the Department of Justice and Johnson & Johnson's Ortho-McNeil Janssen Pharmaceuticals Inc. means sales reps for the company will be monitored with compliance officers who will observe and report on the representatives' behavior on the job. [read post]
12 Sep 2012, 6:14 pm by Mandour & Associates
IPNews® - Johnson & Johnson unit Janssen Pharmaceuticals Inc. won a major patent infringement victory Tuesday when a New Jersey federal judge held that its patent for the popular birth control drug Ortho Tri-Cyclen Lo is valid. [read post]
8 Dec 2016, 12:44 pm by Seeger Weiss
The United States Judicial Panel on Multidistrict Litigation (“JPML”) ordered on Wednesday that 55 active suits against the pharmaceutical company Janssen Pharmaceuticals and its parent corporation Johnson & Johnson, be consolidated in the District of New Jersey under Judge Brian R. [read post]
23 Feb 2010, 9:01 pm by Patent Docs
By Suresh Pillai -- Lupin Claims Tri-Cyclen® Patent Invalid Lupin Pharmaceuticals Inc. has filed counterclaims in its suit with Ortho-McNeil-Janssen Pharmaceuticals Inc., alleging that Ortho's patent covering its Tri-Cyclen® Lo contraceptive, U.S. [read post]
7 Dec 2017, 3:09 pm by Brenda Fulmer
On Tuesday, a jury entered a verdict of $27.8 million against Johnson & Johnson’s Janssen Pharmaceuticals, Inc. and Bayer AG’s Bayer Pharmaceuticals Inc. in the first state court trial out of the Philadelphia County Court of Common Pleas’ mass tort program consolidating Xarelto-related injury lawsuits. [read post]
3 Oct 2011, 9:28 pm by Barry Barnett
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 11-2070 (7th Cir. [read post]
10 Dec 2015, 8:00 pm by John Ehrett
The petition of the day is: Ortho-McNeil-Janssen Pharmaceuticals Inc. v. [read post]
11 Jan 2016, 7:32 am by Associated Press
The justices on Monday let stand a lower court ruling that said Janssen Pharmaceuticals, Inc. should pay the penalties for violations of South Carolina law. [read post]
24 Feb 2020, 8:46 pm by Jeffrey M. Goldstein
Wholesaler acquires Remicade pursuant to a Distribution Agreement with JOM Pharmaceutical Services, Inc. [read post]
25 Jan 2010, 8:42 pm by LaBovick Law
The United States filed a qui tam or False Claims Act complaint against Johnson & Johnson (J&J) and its subsidiary companies Johnson & Johnson Health Care Systems Inc. and Ortho-McNeil-Janssen Pharmaceuticals Inc. [read post]